학술논문
76 Adjuvant Durvalumab post chemoradiotherapy in stage III unresectable non-small cell lung cancer: A retrospective review from the University Hospitals Bristol and Weston NHS Foundation Trusts
Document Type
Abstract
Author
Source
In Lung Cancer April 2024 190 Supplement 1
Subject
Language
ISSN
0169-5002